Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-097031

Director sold 212,477 shares at an average $42.93 ($9,121,902)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kersten Dirk · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-12 Sale : show line 1 in the form 10b5-1 −26,416 $42.74 $1,129,020 1,839,750 I
2024-08-12 Sale : show line 2 in the form 10b5-1 −52,076 $43.42 $2,261,140 1,787,674 I
2024-08-13 Sale : show line 3 in the form 10b5-1 −24,378 $42.08 $1,025,826 1,763,296 I
2024-08-13 Sale : show line 4 in the form 10b5-1 −88,179 $42.78 $3,772,298 1,675,117 I
2024-08-13 Sale : show line 5 in the form 10b5-1 −21,428 $43.57 $933,618 1,653,689 I
Open-market sales · 212,477 sh · avg $42.93 · $9,121,902
Loading xslF345X05/ownership.xml…